News

Date	Title
15 Jun 2022	Alvotech, a Global Pureplay Biosimilars Company, to Debut on Nasdaq Under the Ticker ALVO on June 16
06 Jun 2022	Alvotech and Oaktree Acquisition Corp. II Announce Shareholder Approval of Business Combination
03 Jun 2022	Oaktree Acquisition Corp. II Announces Delisting of its Securities Effective and Conditional Upon Consummation of its Pending Business Combination with Alvotech
07 Dec 2021	Alvotech and Oaktree Acquisition Corp. II Announce Merger Agreement to Create a Leading Publicly-Traded Global Biopharmaceutical Company > Investor Presentation
20 Jan 2021	Hims & Hers Health, Inc. Closes Business Combination and Will Begin Trading on the New York Stock Exchange
12 Jan 2021	Oaktree Acquisition Corp. Announces Extraordinary General Meeting Teleconference Details
06 Jan 2021	Oaktree Acquisition Corp. Reminds Shareholders to Vote in Favor of the Business Combination with Hims & Hers
09 Nov 2020	Oaktree Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing November 9, 2020
29 Oct 2020	Hims & Hers Announces Q3 Update
01 Oct 2020	Hims & Hers, a Multi-Specialty Telehealth Platform, to Become Publicly-Traded via Merger with Oaktree Acquisition Corp. > Investor Presentation
21 Sep 2020	Oaktree Acquisition Corp. II Announces Closing of Initial Public Offering and Partial Exercise of Overallotment Option
16 Sep 2020	Oaktree Acquisition Corp. II Announces Pricing of $225 Million Initial Public Offering
06 Sep 2019	Oaktree Acquisition Corp. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants Commencing September 9, 2019
22 Jul 2019	Oaktree Acquisition Corp. Announces Closing of Initial Public Offering and Full Exercise of Overallotment Option
17 Jul 2019	Oaktree Acquisition Corp. Announces Pricing of $175 Million Initial Public Offering